[
    {
        "molecule_name": "exemplary compounds of the present invention",
        "protein_target_name": "Kras G12C protein",
        "binding_metric": "IC50",
        "value": "<10",
        "unit": "μm",
        "is_logarithmic": false,
        "raw_mentions": "From the results, it can be seen that the exemplary compounds of the present invention have better inhibitory activity against the level of phosphorylated ERK downstream of the cell channel mutated by Kras G12C protein, with IC50 of less than 10 μm, or less than 1000nM, or less than 100nM."
    },
    {
        "molecule_name": "exemplary compounds of the present invention",
        "protein_target_name": "Kras G12C protein",
        "binding_metric": "IC50",
        "value": "<1000",
        "unit": "nM",
        "is_logarithmic": false,
        "raw_mentions": "From the results, it can be seen that the exemplary compounds of the present invention have better inhibitory activity against the level of phosphorylated ERK downstream of the cell channel mutated by Kras G12C protein, with IC50 of less than 10 μm, or less than 1000nM, or less than 100nM."
    },
    {
        "molecule_name": "exemplary compounds of the present invention",
        "protein_target_name": "Kras G12C protein",
        "binding_metric": "IC50",
        "value": "<100",
        "unit": "nM",
        "is_logarithmic": false,
        "raw_mentions": "From the results, it can be seen that the exemplary compounds of the present invention have better inhibitory activity against the level of phosphorylated ERK downstream of the cell channel mutated by Kras G12C protein, with IC50 of less than 10 μm, or less than 1000nM, or less than 100nM."
    }
]